Home Tools
Log in
Cart

Approved / Repurposing

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

Cat No. product name
L3400 Clinical Compound Library A unique collection of 3142 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); 3142 compounds
L4210 NMPA-Approved Drug Library 1319 compounds
L1010 FDA-Approved & Pharmacopeia Drug Library 3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); 3158 compounds
L1000 Approved Drug Library A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); 2863 compounds
L4200 FDA-Approved Drug Library A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); 1729 compounds
L9200 Drug Repurposing Compound Library A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); 4240 compounds
L3410 Preclinical Compound Library A unique collection of 709 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); 709 compounds
Clinical Compound Library
L3400 compounds - 3142
NMPA-Approved Drug Library
L4210 compounds - 1319
FDA-Approved & Pharmacopeia Drug Library
L1010 compounds - 3158
Approved Drug Library
L1000 compounds - 2863
FDA-Approved Drug Library
L4200 compounds - 1729
Drug Repurposing Compound Library
L9200 compounds - 4240
Preclinical Compound Library
L3410 compounds - 709